stateofreform.com
Why DaVita is being regulated, investigated, and sued - State of Reform
Something unusual came out of DaVita Inc. releasing its 4th Quarter 2016 results recently. Specifically, DaVita, known primarily as a large, national provider of dialysis services, projects operating income to fall from $1.849 billion in 2016 to a range of $1.638 billion to $1.775 billion for 2017. In contrast, DaVita’s major national competitor Fresenius expects revenue and …